Man Cho, DPM
Podiatrist · Reston, VANPI 1538470869
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (50.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 47.6% of the total.
Across 61 payments — averaging $132.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$4K
- Arthrex$3K
- Convatec Inc.$191
- Anika Therapeutics, Inc.$106
- Zimmer Biomet$87
- Organogenesis Inc.$72
- plus $313 from 11 others
What the payments were for
- Travel & lodging$2,72234%
- Food & beverage$1,30616%
- Education$4,06450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 12 | $3,851 |
| Arthrex | 25 | $3,471 |
| Convatec Inc. | 3 | $191 |
| Anika Therapeutics, Inc. | 1 | $106 |
| Zimmer Biomet | 1 | $87 |
| Organogenesis Inc. | 5 | $72 |
| Stryker | 3 | $66 |
| Smith+Nephew | 2 | $43 |
| Arteriocyte Medical Systems, Inc. | 1 | $30 |
| Abbott | 1 | $29 |
| Aroa Biosurgery Incorporated | 1 | $26 |
| Vertex | 1 | $26 |
| Acera Surgical, Inc. | 1 | $25 |
| Progenacare Global, LLC | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $19 |
| Paragon 28, Inc. | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$154
- X-Twist$106
How this compares
$8,093 in reported general payments places this provider in the 85th percentile of 126 podiatrist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 35 | $807 |
| Ciclopirox | 22 | $790 |
| CiclopiroxCiclopirox Olamine | 16 | $352 |
| Mupirocin | 20 | $205 |
| Celecoxib | 11 | $202 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $140 |
| Levofloxacin | 12 | $136 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Reston
- John ClementsRoanoke$925K
- Leland GilmoreAlexandria$155K
- Justin PhillinganePetersburg$82K
- Jeremy WaltersSuffolk$60K
- Matthew HopsonWilliamsburg$44K
- Benjamin ProtoNewport News$26K
- Kevin RabieVirginia Beach$18K
- Nelson KellerGrafton$17K
- Robert BoguskiRoanoke$12K
- Stacie BuckNewport News$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.